Bioventus Inc. (BVS) which delivers clinically proven, cost-effective products that help people heal quickly and safely, has kicked off the year with a robust financial performance in the first quarter of 2024.
The company has also raised its revenue forecast, demonstrating confidence in its capacity to sustain momentum and generate additional value for stakeholders throughout the year.
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.